As the number of children affected by clinical obesity and related co-morbidities continued to rise, this practical networking meeting equipped attendees with new ideas and the latest developments to improve clinical outcomes.
Held in Leicester, the engaging and informative programme was chaired by Professor Julian Hamilton-Sheild, who was joined by esteemed colleagues. Together, they offered a comprehensive and insightful approach to the causes, interventions, therapies, and complexities of childhood obesity.
It was a valuable opportunity for peers from across the country to connect, benchmark their services, and explore innovative solutions to shared challenges.
Sponsored by: 
Novo Nordisk has provided sponsorship to SBK to cover the cost of stand space for this meeting. Novo Nordisk has had no influence over the meeting agenda or arrangements.
Rhythm Pharmaceuticals has provided sponsorship to SBK to cover the cost of stand space for this meeting. Rhythm Pharmaceuticals has had no influence over the meeting agenda or arrangements.
5 hours of Continuing Professional Development and networking: what attendees learned
Attendees benefited from a topical, holistic meeting that focused on key developments, the latest evidence, and updates in the management of childhood obesity. They:
- Discovered the latest guidance
- Explored the role of GLP-1s
- Learned about the ENHANCE study and CEW clinic provision
- Gained insight into the genetic causes of childhood obesity
- Improved the management of obesity with Type 2 diabetes
- Tailored their approaches to individual pathways
- Enhanced obesity-related sleep apnoea management
Why attendees chose to attend
This dedicated training day armed attendees with increased knowledge and practical skills to improve their management of childhood obesity. They benefited from:
- Building networks: Gained access to thought leaders and built a community for support, advice, and guidance
- Professional learning: Discovered clinical updates, evidence-based learnings, and real-world examples
- Facilitated discussion: Identified innovative approaches for enhancing pathways and improving patients’ experiences
With thanks to our sponsors
SBK Healthcare would like to thank Novo Nordisk and Rhythm for sponsoring this forum.
Novo Nordisk
has provided sponsorship to SBK to cover the cost of stand space for this
meeting. Novo Nordisk has had no influence over the meeting agenda or
arrangements.
Rhythm
Pharmaceuticals has provided sponsorship to SBK to cover the cost of stand
space for this meeting. Rhythm Pharmaceuticals has had no influence over the
meeting agenda or arrangements.
| 8:30 |
Registration and networking
|
| 9:00 |
Chair’s opening remarks and introductions
Professor Julian Hamilton-Shield, Professor in Diabetes and Metabolic Endocrinology, University of Bristol and The Royal Hospital for Children, University Hospitals Bristol and Weston NHS Foundation Trust
|
| Developments in therapeutics | |
| 9:15 |
Keynote: Exploring the latest guidance and developments in the management of childhood obesity
Sally Abbott, Children’s Transformation Obesity Lead, NHS England
|
| 9:40 |
The role of GLP-1s in the management of clinical childhood obesity
Dr Elizabeth Van Boxel, Paediatric Consultant with special interest in Diabetes and Obesity, University Hospital Southampton NHS Foundation Trust
|
| 10:05 |
Questions and answers with your speakers
|
| 10:15 |
Networking break
|
| 10:35 |
ENHANCE study update: CEW clinic provision across the country
Dr Catherine Homer, Associate Professor of Obesity and Public Health, Sheffield Hallam University and Louisa Ells, Professor of Obesity & Co-director of the Obesity Institute and NIHR Senior Investigator, School of Health, Leeds Beckett University
|
| Exploring childhood obesity causality | |
| 11:00 |
Diagnosing and managing genetic causes for children living with obesity
Dr Helen Stewart, Consultant in Clinical Genetics, Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust
|
| 11:25 |
Questions and answers your speakers
|
| 11:35 |
Interactive discussion: Improving support for children with obesity and Type 2 diabetes
|
| 11:55 |
Feedback from your interactive discussion: Improving support for children with obesity and Type 2 diabetes
|
| 12:05 |
Networking lunch
|
| Management approaches | |
| 1:05 |
Managing clinical obesity with Type 2 Diabetes in children to improve outcomes
Dr Evelien Gevers, Consultant Paediatric Endocrinologist, Royal London Hospital, Barts Health NHS Trust
|
| 1:30 |
Navigating the approaches and options for individual childhood obesity pathways
Dr Mars Skae, Consultant Paediatric Endocrinologist, Lead Clinician for Paediatric Obesity and Disorders of Sex Development, Manchester University NHS Foundation Trust
|
| 1:55 |
Questions and answers with your speakers
|
| 2:05 |
Interactive discussion: Supporting and educating social workers engaging with children living with obesity
|
| 2:25 |
Feedback from your interactive discussion: Supporting and educating social workers engaging with children living with obesity
|
| 2:35 |
Networking break
|
| 2:55 |
Diet and exercise intervention to support weight-loss in childhood obesity
Shelley Easter, Specialist Paediatric Dietitian in Weight Management, Bristol Royal Hospital for Children, University Hospitals Bristol and Weston NHS Foundation Trust
|
| 3:20 |
Questions and answers with your speaker
|
| 3:25 |
Interactive discussion: Providing effective psychological support for children living with obesity
|
| 3:45 |
Feedback from your interactive discussion: Providing effective psychological support for children living with obesity
|
| 3:55 |
Screening and managing obstructive sleep apnoea in children and adolescents with obesity
Dr Katharine Harman, Paediatric Respiratory Physician, King’s College Hospital NHS Foundation Trust
|
| 4:20 |
Questions and answers with your speaker
|
| 4:25 |
Chair’s closing remarks and close of day
|
Novo Nordisk has provided sponsorship to SBK to cover the cost of stand space for this meeting. Novo Nordisk has had no influence over the meeting agenda or arrangements.
Rhythm Pharmaceuticals has provided sponsorship to SBK to cover the cost of stand space for this meeting. Rhythm Pharmaceuticals has had no influence over the meeting agenda or arrangements.
This programme was developed with the support of the educational forum chair, Professor Julian Hamilton-Shield.
With thanks to the speakers
Professor Julian Hamilton-Shield
Professor in Diabetes and Metabolic Endocrinology
University of Bristol and The Royal Hospital for Children, University Hospitals Bristol and Weston NHS Foundation Trust
Sally Abbott
Children’s Transformation Obesity Lead
NHS England
Dr Elizabeth Van Boxel
Paediatric Consultant with special interest in Diabetes and Obesity
University Hospital Southampton NHS Foundation Trust
Dr Catherine Homer
Associate Professor of Obesity and Public Health
Sheffield Hallam University
Louisa Ells
Professor of Obesity & Co-director of the Obesity Institute and NIHR Senior Investigator
School of Health, Leeds Beckett University
Dr Helen Stewart
Consultant in Clinical Genetics, Oxford Centre for Genomic Medicine
Oxford University Hospitals NHS Foundation Trust
Dr Evelien Gevers
Consultant Paediatric Endocrinologist
Royal London Hospital, Barts Health NHS Trust
Dr Mars Skae
Consultant Paediatric Endocrinologist, Lead Clinician for Paediatric Obesity and Disorders of Sex Development
Manchester University NHS Foundation Trust
Shelley Easter
Specialist Paediatric Dietitian in Weight Management
Bristol Royal Hospital for Children, University Hospitals Bristol and Weston NHS Foundation Trust
Dr Katharine Harman
Paediatric Respiratory Physician
King’s College Hospital NHS Foundation Trust
Novo Nordisk has provided sponsorship to SBK to cover the cost of stand space for this meeting. Novo Nordisk has had no influence over the meeting agenda or arrangements.
Rhythm Pharmaceuticals has provided sponsorship to SBK to cover the cost of stand space for this meeting. Rhythm Pharmaceuticals has had no influence over the meeting agenda or arrangements.
Who came?
This meeting was specially created for HCPs working in Complications from Excess Weight (CEW) clinics and services in England and Northern Ireland, Connect in Wales - and Child Healthy Weight programmes in Scotland, as well as those involved in managing childhood obesity and its related co-morbidities throughout the patient pathway. The audience was made up of:
- Consultant Paediatricians
- Consultants in Paediatric Diabetes and Endocrinology
- Clinical Nurse Specialists
- Paediatric Dietitians
- Clinical Psychologists and Psychotherapists
- Youth and Family Support Workers
- Sleep, Exercise, Respiratory and Speech and Language Specialists
Past attendee feedback
This was a quality training event, created following the success of the Obesity Management National Networking Forum held in November 2024. View just some of the feedback from that engaging day here:
View further comments on Diabetes National Networking Forums on Trust Pilot.
Novo Nordisk has provided sponsorship to SBK to cover the cost of stand space for this meeting. Novo Nordisk has had no influence over the meeting agenda or arrangements.
Rhythm Pharmaceuticals has provided sponsorship to SBK to cover the cost of stand space for this meeting. Rhythm Pharmaceuticals has had no influence over the meeting agenda or arrangements.
With thanks to our sponsors
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes.
Novo Nordisk has provided sponsorship to SBK to cover the cost of stand space for this meeting. Novo Nordisk has had no influence over the meeting agenda or arrangements.
Rhythm Pharmaceuticals is a global biopharmaceutical company committed to improving the lives of patients with rare neuroendocrine diseases by developing medicines that address the root cause. For more information, please contact Fleur Taylor at ftaylor@rhythmtx.com . UK-RHY-2500001 I Date of preparation: January 2025.
Rhythm Pharmaceuticals has provided sponsorship to SBK to cover the cost of stand space for this meeting. Rhythm Pharmaceuticals has had no influence over the meeting agenda or arrangements.
Why sponsor?
Our role at SBK Healthcare is to bring industry together with healthcare professionals so that you can educate and inform your audience. These trail-blazing NHS forums offer dedicated presentations, Q&A, networking and discussion time, each sponsor will be fully immersed into the event and able to effectively engage with your NHS audience.
Interested in having your own event, managed by us?
SBK Healthcare also provides in-house forums. Working closely with you as the client we can research, produce, market and deliver the conference or online forum that best suits the audience and meets your goals.
Reach out today
If you would like more information on our sponsorship options an in-house forum or if you wish to discuss your needs and what solutions may be appropriate for your business, please contact:
Vanessa Pearce
Contact: 01732 897788
Email: vanessa.pearce@sbk-healthcare.co.uk
Please login to access documentation associated with the event. This is an exclusive benefit for all of the attendees and includes additional and updated documentation.